Lupkynis (voclosporin) - Aurinia Pharma
Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission. (PubMed, Kidney Int Rep) - Aug 19, 2024 - No abstract available 
Journal • Cardiovascular • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
http://www.ncbi.nlm.nih.gov/pubmed/39156147
 
Farsad Afshinnia; Jaeman Byun; Jennifer L Cross; Linda M Rehaume; Manikanta Swamy Arnipalli; Robert B Huizinga; Subramaniam Pennathur; Thekkelnaycke M Rajendiran
 
Aug 19, 2024
 
Prev Next